Corbus Pharma
CRBP----
Corbus Pharma (CRBP)
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701,...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Corbus Pharma Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$35.30284.95%
Forecast & RatingStrong buy
9analysts
- Strong buy88.89%
- Buy11.11%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- MarketWatch Automated · 1 day ago, 04:21 PM
Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
- MarketWatch Automated · 2 days ago, 04:20 PM
Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
- MarketWatch Automated · Jul 21 at 04:19 PM
Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market
- MarketWatch Automated · Jul 20 at 04:09 PM
Zimmer Biomet Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
- MarketWatch Automated · Jul 9 at 04:18 PM
Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market
- MarketWatch Automated · Jul 8 at 04:17 PM
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
